TESA / IPA Blend: preclinical and in-vitro studies
3 published studies on the components of TESA / IPA Blend, limited by rule to animal models and cell-based (in vitro) work indexed in PubMed, spanning 2002 to 2024 across 3 journals. Human trials, case reports and literature overviews are excluded. Titles appear as published; each links to its PubMed record and, where one is registered, its DOI. TESA / IPA Blend is a blend, so the index lists studies per component: Ipamorelin (3).
- 3studies listed
- 3with an animal model
- 1with in-vitro work
- 2002 to 2024publication years
- 3journals
Evidence table
| # | Year | Study | Journal | Model | Record |
|---|---|---|---|---|---|
| 1 | 2024 | The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicusIpamorelin · PMID 38996787 | Animal reproduction science | Animal model | PubMed · DOI |
| 2 | 2009 | Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileusIpamorelin · PMID 19289567 | The Journal of pharmacology and experimental therapeutics | Rats model | PubMed · DOI |
| 3 | 2002 | Influence of chronic treatment with the growth hormone secretagogue Ipamorelin, in young female rats: somatotroph response in vitroIpamorelin · PMID 12168778 | Histology and histopathology | Rats model and in vitro | PubMed · DOI |
Studies by model
- Rats · 2 studies
- Animal model (species not indexed) · 1 study
- In vitro · 1 study
What this index does not include
Human research of any kind: publications typed by PubMed as human studies or case reports, and papers whose titles or abstracts describe human subjects, are removed by rule. Literature overviews, meta-analyses, editorials and letters are removed because they summarise rather than report. Papers whose titles contain usage or outcome language that would not pass this site's research-use-only copy rules are dropped rather than reworded, since a published title is a fact that cannot be edited.
Nothing on this page is a statement about effects in humans, a recommendation, or a description of the material supplied. TESA / IPA Blend is supplied for laboratory research only.
How this index is built
PubMed is searched on the names the literature uses for the components of TESA / IPA Blend (ipamorelin), restricted to records indexed to an animal or cell model, in English, with an abstract. Clinical publication types, human-subject language and overview-type publications are excluded. The compound must be named in the title. Candidates are ranked by title match, indexing quality and year; the shortlist is read by a person before it is published, and a small blocklist holds records rejected on that read. The list was resolved on 2026-10-12 and is re-run deliberately, never on a timer.
Questions
Are there human studies of TESA / IPA Blend in this index?
No, by design. This index lists animal and cell-based research only. Publications typed as human studies, case reports or literature overviews, and papers whose titles or abstracts describe human subjects, are excluded by rule before anything is listed. Eon Peptides supplies TESA / IPA Blend for laboratory research and makes no statement about use in humans.
Which research models appear most often for TESA / IPA Blend?
Across the 3 studies listed: Rats (2), Animal model (species not indexed) (1), In vitro (1). A model label is taken from PubMed's indexing of each paper, or from its title and abstract when the record is too new to be indexed. It describes the study, not the material.
How are the studies selected?
A PubMed search on the published names of the compound (ipamorelin) is filtered to records indexed to an animal or cell model, with clinical publication types, human-subject language and overview-type publications removed. The compound must be named in the title. Remaining records are ranked by title match, indexing quality and year, and the top 3 are listed after a manual read. The list was resolved against PubMed on 2026-10-12.
Does a listing here say anything about the TESA / IPA Blend Eon Peptides sells?
No. A listing records that a study was published and what it examined. It says nothing about the properties, quality or intended use of any material. What Eon Peptides does document about its own TESA / IPA Blend is on the certificate pages: lot-level identity and purity results from independent laboratories.
Related pages
- TESA / IPA Blend in the catalogueSizes, price and the current certificate
- Ipamorelin study indexThe component's own index
For research use only. Not for human or veterinary use. Preclinical and in-vitro studies only: animal models and cell-based work indexed in PubMed. Human trials, case reports and literature overviews are excluded by rule.